Depression and Anxiety Trial, By Invitation NCT07198542 Sponsor: National Taiwan University Hospital Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, By Invitation

NCT07198542
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • A person must have been diagnosed with Somatic Symptom Disorder (a condition where physical symptoms cause significant distress and are linked to excessive thoughts or feelings) according to standard psychiatric guidelines, confirmed through an interview with a qualified psychiatrist.
  • A person must be receiving ongoing, regular medical care throughout the duration of the trial.
  • A person must not have had any changes made to their psychiatric or heart-related medications for at least one week before the trial begins.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People younger than 18 or older than 65 years of age.
  • People who experience psychotic symptoms, such as those associated with schizophrenia.
  • People with significant memory or thinking difficulties, such as a diagnosis of dementia or intellectual disability, or who would have trouble completing study questionnaires.
  • People who have previously had a surgical procedure to cut the vagus nerve in the neck (cervical vagotomy).
  • People with serious heart or circulation conditions, including a resting heart rate that is too fast (above 100 beats per minute) or too slow (below 60 beats per minute); blood pressure that is significantly too high or too low; severe narrowing of the heart's arteries; narrowing or fatty buildup in the neck arteries; aneurysm; heart failure; serious irregular heart rhythms (such as certain electrical conduction problems, atrial fibrillation, or recent dangerous heart rhythms); or a heart attack within the last five years.
  • People with serious neurological conditions, including severe head trauma, a history of epilepsy, a brain tumour, or bleeding in the brain.
  • People currently diagnosed with cancer.
  • People who have any active implanted medical devices (such as a cochlear implant, pacemaker, or implanted vagus nerve stimulator) or certain non-active implants that may interact with the nervous system (such as metal stents, bone plates, or screws).
  • People with structural abnormalities in the neck area.
  • People who are currently pregnant.
  • People who wear jewellery near the ear (specifically near the tragus) that cannot be removed before using the study device.
  • People with severe skin conditions at the areas where the device would be applied.
  • People with a known allergy to conductive gel materials.
  • People with any other significant medical condition that the trial investigator considers could affect the safety or effectiveness of the treatment being studied.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
17 November 2025
Est. completion
31 December 2028

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Change in Somatic Symptom Severity as Measured by the Patient Health Questionnaire-15 (PHQ-15); Change in Health Anxiety as Measured by the Health Anxiety Questionnaire (HAQ)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov